Ticagrelor with aspirin dual antiplatelet therapy combined with intravenous thrombolysis in patients with ischaemic stroke in China (TAPIS): a multicentre, double-blind, randomised controlled trial.
- DOI
- 10.1016/s0140-6736(26)00757-9
- Published
- 2026-05-08
- Container
- Lancet
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0140-6736-26-00757-9,
title = {Ticagrelor with aspirin dual antiplatelet therapy combined with intravenous thrombolysis in patients with ischaemic stroke in China (TAPIS): a multicentre, double-blind, randomised controlled trial.},
author = {Wang A and Xia X and Tang Y and Zhang F and Han X and Li J and Zhang X and Wang J and Song Y and Che F and Bei Y and He Y and Jing W and Hao J and He J and Yang H and Chen S and Wu W and Li Y and Dai H and Yang C and Sun Z and Li L and Chen Y and Bath PM and Turc G and Wang Y and TAPIS Investigators.},
year = {2026},
journal = {Lancet},
doi = {10.1016/s0140-6736(26)00757-9},
url = {https://doi.org/10.1016/s0140-6736(26)00757-9}
}RIS
TY - JOUR TI - Ticagrelor with aspirin dual antiplatelet therapy combined with intravenous thrombolysis in patients with ischaemic stroke in China (TAPIS): a multicentre, double-blind, randomised controlled trial. AU - Wang A AU - Xia X AU - Tang Y AU - Zhang F AU - Han X AU - Li J AU - Zhang X AU - Wang J AU - Song Y AU - Che F AU - Bei Y AU - He Y AU - Jing W AU - Hao J AU - He J AU - Yang H AU - Chen S AU - Wu W AU - Li Y AU - Dai H AU - Yang C AU - Sun Z AU - Li L AU - Chen Y AU - Bath PM AU - Turc G AU - Wang Y AU - TAPIS Investigators. PY - 2026 JO - Lancet DO - 10.1016/s0140-6736(26)00757-9 UR - https://doi.org/10.1016/s0140-6736(26)00757-9 ER -
APA
A, W., X, X., Y, T., F, Z., X, H., J, L., X, Z., J, W., Y, S., F, C., Y, B., Y, H., W, J., J, H., J, H., H, Y., S, C., W, W., Y, L., H, D., C, Y., Z, S., L, L., Y, C., PM, B., G, T., Y, W., & Investigators., T. (2026). Ticagrelor with aspirin dual antiplatelet therapy combined with intravenous thrombolysis in patients with ischaemic stroke in China (TAPIS): a multicentre, double-blind, randomised controlled trial.. Lancet. https://doi.org/10.1016/s0140-6736(26)00757-9
Source records
- europe-pmc · retrieved 2026-09-26T21:22:08.502Z